Abstract
The therapeutic use of angiotensin converting enzyme (ACE) inhibitors, at a large scale, in arterial hypertension has showed that these molecules can exert beneficial effects on insulin sensitivity and may reduce the occurrence of type 2 diabetes mellitus. One hypothesis explaining these effects of ACE inhibitors may relate to their capacity to interfere with bradykinin (BK) metabolism and action. BK may participate in the regulation of substrate utilization by several tissues by improving blood flow and substrate delivery to the tissues and also by promoting translocation of glucose transporters. Moreover, BK has been shown to increase phosphorylation of insulin receptor and its cell substrates. BK also appears to improve the release of insulin. Furthermore, insulin may activate the kallikrein-kinin system, which consequently may increase its metabolic effects. However, in experimental diabetes mellitus, BK can participate to the inflammatory reaction leading to Langerhans islets destruction. In diabetes, whereas tissue kallikrein mRNA levels were reduced in several organs, an overexpression of kinin receptors, an increase in plasma levels of kininogens and kallikrein and an activation of the kinin system have all been reporte...Continue Reading
Citations
Jun 20, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Paul Ernsberger, Richard J Koletsky
Dec 23, 2008·The Journal of Pharmacology and Experimental Therapeutics·Dale S EdgertonThomas R Strack
Nov 22, 2011·PloS One·David PépinBarbara C Vanderhyden
Jan 15, 2008·Peptides·Viviani Milan Ferreira RastelliZuleica Bruno Fortes
Apr 6, 2007·Peptides·Viviani Milan Ferreira RastelliZuleica Bruno Fortes
Jan 4, 2006·Diabetes/metabolism Research and Reviews·Licio A VellosoMario J A Saad
Nov 22, 2005·European Journal of Pharmacology·Jacques DamasPierre J Lefèbvre
Apr 29, 2015·Journal of Diabetes Research·Xia ZouHai-lu Zhao
Nov 15, 2007·Diabetes Care·Henry R BlackUNKNOWN Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Aug 8, 2014·PloS One·Tadeusz KolodkaMark S Robbins
Sep 27, 2014·PloS One·Lilia Maneva-RadichevaAlexei Y Savinov
Apr 29, 2005·Diabetes/metabolism Research and Reviews
Nov 30, 2006·Diabetes·Dale S EdgertonThomas R Strack
Sep 12, 2006·The Journal of Pharmacology and Experimental Therapeutics·Dale S EdgertonAlan D Cherrington
May 17, 2007·Arquivos brasileiros de endocrinologia e metabologia·Marco A de Carvalho-FilhoMario José Abdalla Saad
Dec 8, 2020·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Martijn HoevenaarJanne Roorda
Mar 16, 2011·Physiological Research·G G SchweitzerG D Cartee